Design and synthesis of IKK1 inhibitors for the treatment of hormone refractory prostate cancer
The transcription factor NF-κB (Nuclear Factor kappa B) mediates the expression of a number of pro-inflammatory cytokines, adhesion molecules, growth factors, and anti-apoptosis survival proteins. NF-κB transcriptional activity is normally suppressed in the cytosol via complexation with its natural...
Main Author: | Mi´nguez, Sabin Llona |
---|---|
Published: |
University of Strathclyde
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.640862 |
Similar Items
-
Synthesis of inhibitors of the IKK-complex for the treatment of prostate cancer
by: Baiget, Jessica
Published: (2012) -
Design, synthesis and biological evaluation of sphingosine kinase inhibitors for the treatment of prostate cancer
by: Tawati, Salha M.
Published: (2018) -
Examination of IKKα inhibitors as novel anti-panceatic cancer drugs
by: Al-Obaidi, Ahlam Ismail Ibrahim
Published: (2017) -
Design and synthesis of inhibitors of the non-canonical NF-ĸB pathway for the treatment of prostate and pancreatic cancer
by: West, Chris
Published: (2016) -
Synthesis and biological evaluation of selective inhibitory kappa B kinase-alpha (IKKa) inhibitors for the treatment of prostate and pancreatic cancer
by: Alsfouk, Aisha
Published: (2018)